XOMA Corp (XOMA)
25.45
+0.09
(+0.35%)
USD |
NASDAQ |
Apr 26, 11:44
XOMA Price to Book Value: 3.337 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 3.325 |
| April 24, 2024 | 3.362 |
| April 23, 2024 | 3.421 |
| April 22, 2024 | 3.385 |
| April 19, 2024 | 3.341 |
| April 18, 2024 | 3.224 |
| April 17, 2024 | 3.179 |
| April 16, 2024 | 3.196 |
| April 15, 2024 | 3.191 |
| April 12, 2024 | 3.389 |
| April 11, 2024 | 3.435 |
| April 10, 2024 | 3.38 |
| April 09, 2024 | 3.358 |
| April 08, 2024 | 3.309 |
| April 05, 2024 | 3.322 |
| April 04, 2024 | 3.383 |
| April 03, 2024 | 3.387 |
| April 02, 2024 | 3.455 |
| April 01, 2024 | 3.310 |
| March 28, 2024 | 3.153 |
| March 27, 2024 | 3.060 |
| March 26, 2024 | 3.035 |
| March 25, 2024 | 3.147 |
| March 22, 2024 | 3.252 |
| March 21, 2024 | 3.216 |
| Date | Value |
|---|---|
| March 20, 2024 | 3.228 |
| March 19, 2024 | 3.304 |
| March 18, 2024 | 3.301 |
| March 15, 2024 | 3.451 |
| March 14, 2024 | 3.379 |
| March 13, 2024 | 3.358 |
| March 12, 2024 | 3.363 |
| March 11, 2024 | 3.446 |
| March 08, 2024 | 3.240 |
| March 07, 2024 | 3.294 |
| March 06, 2024 | 3.278 |
| March 05, 2024 | 3.224 |
| March 04, 2024 | 3.274 |
| March 01, 2024 | 3.228 |
| February 29, 2024 | 3.152 |
| February 28, 2024 | 3.234 |
| February 27, 2024 | 3.158 |
| February 26, 2024 | 3.210 |
| February 23, 2024 | 3.023 |
| February 22, 2024 | 3.026 |
| February 21, 2024 | 3.176 |
| February 20, 2024 | 2.888 |
| February 16, 2024 | 2.999 |
| February 15, 2024 | 2.875 |
| February 14, 2024 | 2.645 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.350
Minimum
Sep 13 2022
13.21
Maximum
Dec 21 2020
3.859
Average
2.964
Median
Price to Book Value Benchmarks
| Kinnate Biopharma Inc (DELISTED) | 0.7855 |
| Societal CDMO Inc (DELISTED) | 1.982 |
| Corcept Therapeutics Inc | 4.658 |
| Sarepta Therapeutics Inc | 14.20 |
| AbbVie Inc | 27.50 |
Price to Book Value Related Metrics
| PS Ratio | 61.36 |
| PEG Ratio | -0.0599 |
| Price | 25.45 |
| Earnings Yield | -15.87% |
| Market Cap | 295.88M |